141 related articles for article (PubMed ID: 17537857)
1. Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity.
Kim MS; Racaniello VR
J Virol; 2007 Aug; 81(16):8648-55. PubMed ID: 17537857
[TBL] [Abstract][Full Text] [Related]
2. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
Karnauchow TM; Tolson DL; Harrison BA; Altman E; Lublin DM; Dimock K
J Virol; 1996 Aug; 70(8):5143-52. PubMed ID: 8764022
[TBL] [Abstract][Full Text] [Related]
3. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.
Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM
J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.
Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR
J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298
[TBL] [Abstract][Full Text] [Related]
5. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
[TBL] [Abstract][Full Text] [Related]
6. Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.
Haddad A; Nokhbeh MR; Alexander DA; Dawe SJ; Grisé C; Gulzar N; Dimock K
J Virol; 2004 Mar; 78(6):2674-81. PubMed ID: 14990687
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.
Nokhbeh MR; Hazra S; Alexander DA; Khan A; McAllister M; Suuronen EJ; Griffith M; Dimock K
J Virol; 2005 Jun; 79(11):7087-94. PubMed ID: 15890948
[TBL] [Abstract][Full Text] [Related]
8. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.
Rezaikin AV; Novoselov AV; Sergeev AG; Fadeyev FA; Lebedev SV
Virus Res; 2009 Oct; 145(1):74-9. PubMed ID: 19540285
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of enterovirus 70 capsid protein VP1 and its non-overlapping N- and C-terminal fragments.
Chen D; Duggan C; Texada DE; Reden TB; Kooragayala LM; Langford MP
Antiviral Res; 2005 Jun; 66(2-3):111-7. PubMed ID: 15911028
[TBL] [Abstract][Full Text] [Related]
10. Structure of Human Enterovirus 70 and Its Inhibition by Capsid-Binding Compounds.
Füzik T; Moravcová J; Kalynych S; Plevka P
J Virol; 2022 Sep; 96(17):e0060422. PubMed ID: 35939401
[TBL] [Abstract][Full Text] [Related]
11. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.
Johansson ES; Xing L; Cheng RH; Shafren DR
J Virol; 2004 Nov; 78(22):12603-12. PubMed ID: 15507647
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid functions in enterovirus 70 binding and infection.
Alexander DA; Dimock K
J Virol; 2002 Nov; 76(22):11265-72. PubMed ID: 12388686
[TBL] [Abstract][Full Text] [Related]
14. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.
Polacek C; Ekström JO; Lundgren A; Lindberg AM
Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091
[TBL] [Abstract][Full Text] [Related]
15. Enterovirus strain and type-specific differences in growth kinetics and virus-induced cell destruction in human pancreatic duct epithelial HPDE cells.
Smura T; Natri O; Ylipaasto P; Hellman M; Al-Hello H; Piemonti L; Roivainen M
Virus Res; 2015 Dec; 210():188-97. PubMed ID: 26260332
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution controls DAF-dependent phenotype of echovirus 11 in rhabdomyosarcoma cells.
Novoselov AV; Rezaykin AV; Sergeev AG; Fadeyev FA; Grigoryeva JV; Sokolova ZI
Virus Res; 2012 Jun; 166(1-2):87-96. PubMed ID: 22445689
[TBL] [Abstract][Full Text] [Related]
17. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.
Carson SD; Chapman NM; Hafenstein S; Tracy S
J Virol; 2011 Apr; 85(7):3306-14. PubMed ID: 21270163
[TBL] [Abstract][Full Text] [Related]
18. An antiviral small-interfering RNA simultaneously effective against the most prevalent enteroviruses causing acute hemorrhagic conjunctivitis.
Jun EJ; Won MA; Ahn J; Ko A; Moon H; Tchah H; Kim YK; Lee H
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):58-63. PubMed ID: 20739472
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid.
Tresnan DB; Southard L; Weichert W; Sgro JY; Parrish CR
Virology; 1995 Aug; 211(1):123-32. PubMed ID: 7645206
[TBL] [Abstract][Full Text] [Related]
20. Development of RNA interference (RNAi) as potential antiviral strategy against enterovirus 70.
Tan EL; Marcus KF; Poh CL
J Med Virol; 2008 Jun; 80(6):1025-32. PubMed ID: 18428147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
